-
FDA clears narrow use of Lynparza in early prostate cancer — AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral --FDA approves Pfizer’s RSV vaccine for older adults -- See more on our front page news http://bit.ly/w28kSd See more on our front page newsDismiss Notice
Bob Gilot, AstraZeneca Executive Business Director
Discussion in 'Ask a Whistleblower Attorney' started by anonymous, Jun 23, 2021 at 5:39 AM.
Tags:
Add Tags